Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2029?

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2029? It is currently trading at a 48% probability on Kalshi. Scheduled resolution: January 1, 2032.

Last updated October 16, 2026 at 6:52 AM ET

Current Market Probability

Probability Price Platform Status Resolution date Chart
48% 0.48 Kalshi Open January 01, 2032 View chart

Market Information

Historical Market Probability

7 days ago 30 days ago Current
48% 53% 48%

Related Prediction Markets

Popular Prediction Markets